背景:经支气管微波消融术治疗肺结节越来越受欢迎。然而,胸膜下肺结节的微波消融术由于胸膜和消融区之间的距离,引起了人们对胸膜基并发症的担忧.
方法:在2019年3月至2022年11月期间接受经支气管微波消融术的患者被纳入本分析。肺结节分为胸膜下组-距离最近的胸膜表面小于5毫米;深结节组-距离最近的胸膜表面大于或等于5毫米。对胸膜下肺结节消融的安全性进行了审查。
结果:治疗77例患者的82个肺结节(n=82)。平均结节大小为14.2±5.50mm。技术成功率为100%。平均手术时间为133分钟。胸膜下和深结节组之间的并发症发生率和住院时间无统计学差异。21个结节发生并发症(25.6%)。未报告轻微气胸。总共观察到5例气胸需要引流(胸膜下结节[n=2]为6.06%,深结节6.12%[n=3],p=0.991)。共观察到7例胸膜炎性胸痛(胸膜下结节[n=4]为12.1%,深结节6.12%[n=3],p=0.340)。
结论:这项单中心回顾性分析发现,胸膜下和非胸膜下肺结节消融术的安全性结果没有显著差异。队列中并发症的总体发生率较低。这表明经支气管微波对大多数肺结节是可行且安全的。
BACKGROUND: Transbronchial microwave ablation in treating lung nodules is gaining popularity. However, microwave ablation in subpleural lung nodules raised concerns about pleural-based complications due to the proximity between the pleura and the ablation zone.
METHODS: Patients who underwent transbronchial microwave ablation between March 2019 and November 2022 were included in this analysis. The lung nodules were categorized into the subpleural group-less than 5 mm distance to the nearest pleural surface; the deep nodule group-larger or equal to 5 mm distance to the nearest pleural surface. A review of the safety profile of subpleural lung nodule ablation was conducted.
RESULTS: Eighty-two lung nodules (n = 82) from 77 patients were treated. The mean nodule size was 14.2 ± 5.50 mm. The technical success rate was 100%. The mean procedural time was 133 min. No statistically significant differences were detected in the complication rate and the length of stay between the subpleural and deep nodule groups. Complications occured in 21 nodules (25.6%). No minor pneumothorax was reported. Total five cases of pneumothorax required drainage were observed (6.06% in subpleural nodules [n = 2] vs. 6.12% in deep nodules [n = 3], p = 0.991). Total seven cases of pleuritic chest pain were observed (12.1% in subpleural nodules [n = 4] vs. 6.12% in deep nodules [n = 3], p = 0.340).
CONCLUSIONS: This single-center retrospective analysis found no significant difference in the safety outcomes between subpleural and nonsubpleural lung nodule ablation. The overall rate of complications was low in the cohort. This demonstrated that transbronchial microwave was feasible and safe for most lung nodules.